With the UK and the European Union now on divergent paths because of Brexit, what is the state of play for regulating hemp and CBD across the pond and where are the opportunities?
With the first full season of hemp agriculture in Texas underway, Santé Labs, an Austin-based analytical lab and contract manufacturing development firm, said it is ready to help hemp farmers with reliable THC level testing.
Cannabidiol (CBD) may have its uses as a performance-enhancer in sports after a review outlines the compound’s role in reducing inflammation and anxiety as well as increasing the quality of sleep.
CBD manufacturer CV Sciences has reported a sharp drop in revenue, but company officials said wider distribution and new launches—including a product that contains no CBD—promise a bright future.
A bill before the California State legislature would open the country’s largest market to dietary supplements and foods containing CBD, but advocates say time is running out while the machinery of state government is preoccupied with pandemic concerns.
The US Food and Drug Administration may be willing to sit down with a company about a possible NDI submission for full-spectrum hemp extracts, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).
AmericanMarijuana.org recently surveyed over 1,000 consumers who give their pets Cannabidiol (CBD). The survey aimed to gauge the attitudes of pet owners, their veterinarians, and what factors influenced their decisions.
Many recent warning letters from the Federal Trade Commission about COVID-19 are warranted, says UNPA’s Loren Israelsen, but some targeting health practitioners and what our industry has to offer in the broader immunity discussion may hint at redefining...
An amendment to a military funding bill would make it possible for military personnel to openly use hemp/CBD products for the first time. While advocates welcome the development, there is little prospect that CBD products will become part of standard...
FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.
An FDA report on the CBD marketplace reveals that many of the products tested contain THC that was not identified on the labels. In addition, a majority of the products did not meet label claim for CBD content, with either too little or too much CBD.
It’s been promoted for relaxation, muscle spasms, depression, gastrointestinal issues, and more. Now, a number of products claim cannabidiol can help in the bedroom.
With the UK Food Standards Agency (FSA) setting 31 March 2021 as the deadline for firms to have validated novel foods application for its CBD products, how are firms responding to this challenge especially in the current climate?
